These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25638558)

  • 1. UK committee recommends HPV vaccination for MSM.
    Kirby T
    Lancet Oncol; 2015 Jan; 16(1):e7. PubMed ID: 25638558
    [No Abstract]   [Full Text] [Related]  

  • 2. Perspective: Vaccinate boys too.
    Stanley M
    Nature; 2012 Aug; 488(7413):S10. PubMed ID: 22932433
    [No Abstract]   [Full Text] [Related]  

  • 3. Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(50):1705-8. PubMed ID: 22189893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quadrivalent human papillomavirus (HPV) types 6, 11, 16, 18 vaccine for the prevention of genital warts in males: profile report. demail@springer.com.
    Garnock-Jones KP; Giuliano AR
    Drugs R D; 2012 Dec; 12(4):235-8. PubMed ID: 23017129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bug breakfast in the bulletin: the early impact of the national HPV vaccination program.
    Quinn E; Donovan B; Sheppeard VK
    N S W Public Health Bull; 2012 Dec; 23(9-10):208. PubMed ID: 23442998
    [No Abstract]   [Full Text] [Related]  

  • 6. Start early to prevent genital HPV infection-and cervical cancer.
    Heavey E
    Nursing; 2008 May; 38(5):62-3. PubMed ID: 18431214
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):630-2. PubMed ID: 20508594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quadrivalent human papillomavirus vaccine: updated recommendations for males.
    Heesch CB; Hayney MS
    J Am Pharm Assoc (2003); 2012; 52(2):289-90. PubMed ID: 22370386
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of HPV-associated neoplasias by vaccination - short version of the German S3 (level 3) guideline].
    Gross G; Gissmann L; Hillemanns P; Ikenberg H; Kaufmann AM; Petry KU; Pfister H; Schneede P; Schneider A; Smola S;
    Dtsch Med Wochenschr; 2010 May; 135(21):1083-6. PubMed ID: 20486060
    [No Abstract]   [Full Text] [Related]  

  • 10. What about the boys?
    Jayabarathan A
    Can Fam Physician; 2008 Oct; 54(10):1375; author reply 1377. PubMed ID: 18854456
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diseases caused by human papillomavirus -- the possibilities and the public health advantages of prevention].
    Acs N; Bata Z; Danko D; Hernádi Z; Kálmán M; Kornya L; Kovács J; Mézáros G; Molnár MP; Mór Z; Novák Z; Sobel G; Szentirmay Z; Takács L; Tisza T
    Orv Hetil; 2012 Dec; 153 Suppl():3-38. PubMed ID: 23687666
    [No Abstract]   [Full Text] [Related]  

  • 12. [Papillomavirus and cancers: plea for extending the vaccination to boys].
    Abramowitz L; Descamps P; Denis F; Dommergues MA; Lacau St Guily J; Lefebvre JL; Masse G; Judlin P
    Bull Cancer; 2014; 101(7-8):657-62. PubMed ID: 25091647
    [No Abstract]   [Full Text] [Related]  

  • 13. HPV vaccination: should it be mandatory for entry into public school?
    Gray JR
    Nurs Womens Health; 2007 Apr; 11(2):133-8. PubMed ID: 17883794
    [No Abstract]   [Full Text] [Related]  

  • 14. [Condyloma typing important for follow up of HPV vaccination. A condyloma reporting project].
    Sturegård E; Johnsson A; Gustafsson E; Dillner J
    Lakartidningen; 2008 Dec 10-16; 105(50):3648-50. PubMed ID: 19177930
    [No Abstract]   [Full Text] [Related]  

  • 15. The HPV vaccine controversy.
    Intlekofer KA; Cunningham MJ; Caplan AL
    Virtual Mentor; 2012 Jan; 14(1):39-49. PubMed ID: 23116916
    [No Abstract]   [Full Text] [Related]  

  • 16. Gender-neutrality, herd effect and resilient immune response for sustainable impact of HPV vaccination.
    Lehtinen M; Apter D
    Curr Opin Obstet Gynecol; 2015 Oct; 27(5):326-32. PubMed ID: 26308204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current immunization committee includes vaccination against human papillomaviruses in the immunization schedule].
    Kinderkrankenschwester; 2007 May; 26(5):205. PubMed ID: 17550093
    [No Abstract]   [Full Text] [Related]  

  • 18. Human Papillomavirus Vaccination: ACOG Committee Opinion, Number 809.
    American College of Obstetricians and Gynecologists' Committee on Adolescent Health Care, American College of Obstetricians and Gynecologists' Immunization, Infectious Disease, and Public Health Preparedness Expert Work Group
    Obstet Gynecol; 2020 Aug; 136(2):e15-e21. PubMed ID: 32732766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A brief history of economic evaluation for human papillomavirus vaccination policy.
    Beutels P; Jit M
    Sex Health; 2010 Sep; 7(3):352-8. PubMed ID: 20719227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception?
    Licht AS; Murphy JM; Hyland AJ; Fix BV; Hawk LW; Mahoney MC
    Sex Transm Infect; 2010 Feb; 86(1):74-8. PubMed ID: 19841004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.